SII pauses trials of COVID-19 vaccine candidate Covishield in India
The company took this step after the DCGI issued a show cause notice to the company for not informing it about AstraZeneca…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
DCGI issues notice to Serum Institute over AstraZeneca-Oxford COVID-19 vaccine trial suspension
If DCGI has any safety concerns, we will follow their instructions and abide by the standard protocol, said SII in response to…
AstraZeneca stops COVID-19 vaccine trial due to unexplained illness in participant
A participant was found to have transverse myelitis, an inflammatory syndrome that affects the spinal cord and is often sparked by…
NPPA is readying mechanism to ease COVID-19 vaccine supply, prevent unethical practices
The government is in talks with experts and stakeholders to increase access to COVID-19 vaccines, bring down their costs and…
Nine COVID-19 vaccine makers sign safety pledge
The companies said in a statement they would uphold the integrity of the scientific process as they work towards potential global…
Hamdard Labs starts clinical trials of two drugs to evaluate efficacy to prevent COVID-19 infection
After regulatory approval from AYUSH ministry, the clinical trials are being conducted at HAH Centenary Hospital, New Delhi
UNICEF to pilot acquisition, distribution of COVID-19 vaccines
The effort, involving over 170 economies, has the potential to become the world's largest and fastest ever operation of its kind
Bharat Biotech gets DCGI nod for PHASE II trials of COVAXIN
The subject expert committee (SEC) has recommended that the trial will be conducted on 380 participants
COVID-19 vaccine makers to prepare joint pledge for safety
The companies would pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and in their…
BDR Pharma to launch 400 mg Favipiravir tablets
The 400 mg tablets will be priced at Rs 990 for a strip of 10 tablets
COVID-19 slashes pharma production in Uttarakhand
Hoping for revival, pharma units based in Haridwar plan to start 100 per cent production from next week
Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19:…
Six of Sanofi’s clinical trials, which were being conducted in 31 countries, have been disrupted, which might impact the company's…
To accelerate recovery of pharma ancillary industry, primary focus should be financial relief to…
Rishabh Bindlish, MD, India Life Sciences and Global Generics Lead, Accenture in India talks about the measures needed to revive…
CureVac expects to produce COVID-19 vaccine at scale by year-end
It is one of a number of firms developing vaccines based on molecules carrying a genetic code called messenger RNA (mRNA) to treat…
Sanofi, GSK initiate Phase 1/2 clinical trial of COVID-19 vaccine candidate
440 participants are being enrolled in the trial across 11 investigational sites in the US, companies expect first results in…
Prep for COVID-19 vaccine distribution as soon as late October: US CDC
An earlier report had informed that the CDC had contacted officials in all 50 states and five large cities with the planning…
67 per cent experts to use decentralised clinical trials in near future due to COVID-19: GlobalData
Majority of respondents also consider the cost of decentralised clinical trials to be lower than that of traditional trials
Novavax and Canada reach agreement in principle for 76 mn doses of COVID-19 vaccine
NVX-CoV2373 is currently in multiple Phase 2 clinical trials
Phase III trials of AstraZeneca COVID-19 vaccine candidate begins in US
AZD1222 is already undergoing late-stage clinical trials in Britain, Brazil and South Africa, with additional trials planned in…
GSK, Vir Biotech to test COVID-19 antibody treatment
The long-acting single injection will be tested on recently diagnosed high-risk cases for its ability to prevent hospitalisation